Prospective multicenter trial: Hormonal changes by switching from GnRH agonist to GnRH antagonist in patients with early stage of castration resistant prostate cancer as a second line hormonal therapy

التفاصيل البيبلوغرافية
العنوان: Prospective multicenter trial: Hormonal changes by switching from GnRH agonist to GnRH antagonist in patients with early stage of castration resistant prostate cancer as a second line hormonal therapy
المؤلفون: Akitoshi Takizawa, Junichi Ohta, Kazuki Kobayashi, Yumiko Yokomizo, Masahiro Yao, Narihiko Hayashi, Kazuo Kitami, Takeshi Kishida, Hiroji Uemura
المصدر: Journal of Clinical Oncology. 36:e17030-e17030
بيانات النشر: American Society of Clinical Oncology (ASCO), 2018.
سنة النشر: 2018
مصطلحات موضوعية: Agonist, Oncology, endocrine system, Cancer Research, medicine.medical_specialty, medicine.drug_class, business.industry, GnRH Antagonist, medicine.disease, Prostate cancer, Internal medicine, Multicenter trial, medicine, Hormonal therapy, Progression-free survival, Stage (cooking), business, hormones, hormone substitutes, and hormone antagonists, Hormone
الوصف: e17030Background: It was reported that GnRH antagonist could extend progression free survival for prostate cancer patients significantly longer than GnRH agonist in a first line hormonal therapy. H...
تدمد: 1527-7755
0732-183X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f7040b9578b41160b8d61972a19e2639
https://doi.org/10.1200/jco.2018.36.15_suppl.e17030
رقم الأكسشن: edsair.doi...........f7040b9578b41160b8d61972a19e2639
قاعدة البيانات: OpenAIRE